OREXIGEN THERAPEUTICS INC's ticker is OREXQ and the CUSIP is 686164302. A total of 53 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 17.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $8,000 | -88.7% | 39,243 | -29.7% | 0.00% | – |
| Q4 2017 | $71,000 | -48.6% | 55,853 | -14.0% | 0.00% | – |
| Q3 2017 | $138,000 | -33.3% | 64,940 | -8.8% | 0.00% | – |
| Q2 2017 | $207,000 | -55.0% | 71,240 | -46.7% | 0.00% | – |
| Q1 2017 | $460,000 | +1816.7% | 133,580 | +865.2% | 0.00% | – |
| Q4 2016 | $24,000 | -41.5% | 13,840 | +13.5% | 0.00% | – |
| Q3 2016 | $41,000 | – | 12,193 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 542,755 | $944,000 | 0.47% |
| BVF INC/IL | 734,976 | $1,279,000 | 0.26% |
| Old West Investment Management, LLC | 206,018 | $358,000 | 0.22% |
| Foresite Capital Management III, LLC | 254,257 | $442,000 | 0.19% |
| Baupost Group | 2,226,839 | $3,875,000 | 0.05% |
| Rhenman & Partners Asset Management AB | 120,000 | $209,000 | 0.04% |
| NEA Management Company, LLC | 370,900 | $645,000 | 0.03% |
| Rock Springs Capital Management LP | 165,300 | $288,000 | 0.02% |
| TWO SIGMA SECURITIES, LLC | 22,934 | $40,000 | 0.01% |
| Telemetry Investments, L.L.C. | 10,250 | $18,000 | 0.01% |